Literature DB >> 1968168

5 alpha-reductase activity in polycystic ovary syndrome.

P M Stewart1, C H Shackleton, G H Beastall, C R Edwards.   

Abstract

11 patients with polycystic ovary syndrome (hirsutism and oligomenorrhoea), but with no deficiency of 21-hydroxylase or 3 beta-hydroxysteroid dehydrogenase, had abnormal cortisol metabolism. The high ratio of 5 alpha to 5 beta cortisol metabolites in the urine is consistent with enhanced activity of 5 alpha-reductase. Urinary total cortisol metabolites were higher in patients than controls. Increased 5 alpha-reductase activity in liver and skin enhances hepatic cortisol metabolism at the expense of androgen excess and may be the underlying abnormality in polycystic ovary syndrome.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1968168     DOI: 10.1016/0140-6736(90)90664-q

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  29 in total

Review 1.  Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions.

Authors:  Kristen Farrell; Michael H Antoni
Journal:  Fertil Steril       Date:  2010-05-14       Impact factor: 7.329

Review 2.  Hirsutism: pilosebaceous unit dysregulation. Role of peripheral and glandular factors.

Authors:  V Toscano
Journal:  J Endocrinol Invest       Date:  1991-02       Impact factor: 4.256

Review 3.  Dermatology.

Authors:  M H Rustin
Journal:  Postgrad Med J       Date:  1990-11       Impact factor: 2.401

Review 4.  New perspectives on the definition and management of polycystic ovary syndrome.

Authors:  R Pasquali; A Gambineri
Journal:  J Endocrinol Invest       Date:  2018-01-23       Impact factor: 4.256

5.  Stimulatory effect of insulin on 5alpha-reductase type 1 (SRD5A1) expression through an Akt-dependent pathway in ovarian granulosa cells.

Authors:  Pradeep P Kayampilly; Brett L Wanamaker; James A Stewart; Carrie L Wagner; K M J Menon
Journal:  Endocrinology       Date:  2010-09-01       Impact factor: 4.736

6.  CYP17 gene analysis in hyperandrogenised women with and without exaggerated 17-hydroxyprogesterone response to ovarian stimulation.

Authors:  M Liović; J Prezelj; A Kocijancic; G Majdic; R Komel
Journal:  J Endocrinol Invest       Date:  1997-04       Impact factor: 4.256

Review 7.  Childhood obesity and its impact on the development of adolescent PCOS.

Authors:  Amy D Anderson; Christine M Burt Solorzano; Christopher R McCartney
Journal:  Semin Reprod Med       Date:  2014-04-08       Impact factor: 1.303

8.  AMPK activation by dihydrotestosterone reduces FSH-stimulated cell proliferation in rat granulosa cells by inhibiting ERK signaling pathway.

Authors:  Pradeep P Kayampilly; K M J Menon
Journal:  Endocrinology       Date:  2012-03-27       Impact factor: 4.736

9.  Age, body mass index, and serum level of DHEA-S can predict glucocorticoid receptor function in women with polycystic ovary syndrome.

Authors:  Djuro Macut; Danijela Vojnović Milutinović; Ivana Božić; Gordana Matić; Jelena Brkljačić; Dimitrios Panidis; Milan Petakov; Nikolaos Spanos; Jelica Bjekić; Olivera Stanojlović; Anđela Petrović Milinković; Zoran Radojičić; Svetozar Damjanović
Journal:  Endocrine       Date:  2009-11-17       Impact factor: 3.633

Review 10.  Polycystic ovary syndrome and insulin resistance: thrifty genes struggling with over-feeding and sedentary life style?

Authors:  J Holte
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.